Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Icy Hot Pro-Therapy is a high-strength topical analgesic formulation developed for the temporary relief of minor aches and pains associated with arthritis, simple backache, muscle strains, sprains, and bruises. Unlike the standard Icy Hot formulations that typically combine menthol and methyl salicylate, the Pro-Therapy line utilizes a potent combination of menthol (16%) and camphor (11%). These active ingredients function as counterirritants; menthol targets the TRPM8 receptors to induce a cooling sensation, while camphor interacts with TRPV receptors to produce a warming effect and increase local blood flow. This dual-action sensory stimulation desensitizes nociceptive pathways and provides a competitive stimulus that distracts the central nervous system from underlying musculoskeletal pain. It is marketed as a professional-grade over-the-counter solution for athletes and individuals with chronic joint or muscle discomfort.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Icy Hot Pro-Therapy.